Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study

Table 5 Patient characteristics at baseline, stratified by availability for follow-up analysis

Characteristics	Entire cohort	Excluded cohort^a	Included cohort	p-value^b
	N = 458	N = 324	N = 134
Demographic characteristics
Age median (IQR)	45 (34, 62)	47 (36, 63)	42 (30, 57)	0.022
Male, No. (%)	185 (40.4%)	141 (43.5%)	44 (32.8%)	0.034
Initial clinical condition
Lower ARTI (%)	248 (54.1%)	173 (53.4%)	75 (56.0%)	0.61
Upper ARTI (%)	210 (45.9%)	151 (46.6%)	59 (44.0%)	0.61
ProADM at baseline (pmol/L)	N = 163	N = 33	N = 130
median (IQR)	.3 (.1, .5)	.4 (.2, .5)	.3 (.1, .5)	0.022
mean (SD)	.4 (.3)	.4 (.3)	.4 (.4)	0.29
ProADM at day 7 (pmol/L)	N = 151	N = 28	N = 123
median (IQR)	.2 (.1, .4)	.4 (.2, .5)	.2 (.1, .4)	0.012
mean (SD)	.3 (.3)	.4 (.3)	.3 (.3)	0.033

Data are presented as median (IQR), mean (SD) or % (no.). p values are statistically significant at p < 0.05
IQR Interquartile range (25th–75th percentiles), SD Standard deviation, ARTI Acute respiratory tract infection
^aNo ProADM blood levels measured or lost to follow-up, ^b Included cohort versus excluded cohort

ISSN: 1471-2261